APA

Tzur S., Rosset S., Shemer R., Yudkovsky G., Selig S., Tarekegn A., Bekele E., Bradman N., Wasser W. G., Behar D. M. & Skorecki K. (20100907). Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. : Human genetics.

Chicago

Tzur Shay, Rosset Saharon, Shemer Revital, Yudkovsky Guennady, Selig Sara, Tarekegn Ayele, Bekele Endashaw, Bradman Neil, Wasser Walter G, Behar Doron M and Skorecki Karl. 20100907. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. : Human genetics.

Harvard

Tzur S., Rosset S., Shemer R., Yudkovsky G., Selig S., Tarekegn A., Bekele E., Bradman N., Wasser W. G., Behar D. M. and Skorecki K. (20100907). Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. : Human genetics.

MLA

Tzur Shay, Rosset Saharon, Shemer Revital, Yudkovsky Guennady, Selig Sara, Tarekegn Ayele, Bekele Endashaw, Bradman Neil, Wasser Walter G, Behar Doron M and Skorecki Karl. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. : Human genetics. 20100907.